Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

NBIXNBIX
3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in NEUROCRINE BIOSCIENCES INC

BlackRock Finance, Inc. holds 14.2M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $2B as of 2024-Q2. The position was increased (+3.1% shares). NBIX represents 0.0% of BlackRock Finance, Inc.'s portfolio.

Current Value

$2B

Current Shares

14.2M

Total Value Change

+$155.4M

Total Shares Change

+542,817

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Increased
14.2M
+3.1%
$2B0.0%$137.67
33
2024-Q1
Increased
13.8M
+0.8%
$1.9B0.0%$137.92
32
2023-Q4
New
13.6M
-
$1.8B0.0%$131.76
44

Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used